Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$4.39 - $5.66 $44,339 - $57,166
-10,100 Closed
0 $0
Q1 2019

May 07, 2019

SELL
$3.19 - $5.73 $123,800 - $222,375
-38,809 Reduced 79.35%
10,100 $70,000
Q4 2018

Feb 12, 2019

SELL
$2.95 - $4.15 $63,661 - $89,557
-21,580 Reduced 30.61%
48,909 $188,000
Q3 2018

Nov 13, 2018

BUY
$3.91 - $4.66 $37,696 - $44,927
9,641 Added 15.84%
70,489 $375,000
Q2 2018

Aug 08, 2018

BUY
$3.86 - $7.61 $8,291 - $16,346
2,148 Added 3.66%
60,848 $298,000
Q1 2018

May 10, 2018

BUY
$6.24 - $9.15 $299,520 - $439,200
48,000 Added 448.6%
58,700 $472,000
Q4 2017

Feb 12, 2018

BUY
$7.99 - $11.87 $85,493 - $127,008
10,700
10,700 $109,000

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.